Ic50 Value
Ic50 Value - Related Videos
09:31
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
0 Views •
Cited by 53 •
2017
We describe the use of a phenotypic fluorescence-based neuraminidase inhibition assay to assess the susceptibility of influenza A and B viruses to the neuraminidase inhibitor class of antivirals.
09:38
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
0 Views •
Cited by 5 •
2017
An in vitro method for establishing dual resistance to an EGFR-TKI and a MET-TKI in cancer cells is described. This method is useful for developing treatments for patients with EGFR-mutations, who exhibit disease progression despite EGFR-TKI treatment with MET-amplification. It can also be modified for inhibitors targeting other molecules.
06:51
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
0 Views •
Cited by 4 •
2021
This protocol presents a technique for probing protein-protein interactions using glutathione-linked donor beads with GST-fused TPR-motif co-chaperones and acceptor beads coupled with an Hsp90-derived peptide. We have used this technique to screen small molecules to disrupt Hsp90-FKBP51 or Hsp90-FKBP52 interactions and identified potent and selective Hsp90-FKBP51 interaction inhibitors.
08:48
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
0 Views •
Cited by 7 •
2021
We describe a high-throughput colorimetric assay measuring β-galactosidase activity in three life cycle stages of Trypanosoma cruzi, the causative agent of Chagas disease. This assay can be used to identify trypanocidal compounds in an easy, fast, and reproducible manner.
07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
0 Views •
2025
Plasmodium sexual development occurs in the mosquito midgut. Targeting the parasite's sexual stages is a promising strategy to block transmission. We developed Ookluc, a transgenic P. berghei expressing nanoluciferase after zygote formation, enabling high-throughput screening of transmission-blocking compounds. This article details the methods for screening using Ookluc.
FAQs
An IC50 value is obtained by fitting measured responses across several compound concentrations to a concentration-response curve, rather than by reading a single experimental point. The fitted curve identifies the concentration corresponding to the 50% inhibition level. This approach converts a series of assay observations into a quantitative potency estimate and helps accommodate the overall response pattern.
The measured value is conditional on the assay environment. Substrate concentration can influence apparent inhibition in enzyme assays, while incubation time and the experimental system can alter the observed response. Consequently, two studies testing the same compound may report different values if these variables differ. Recording and controlling them is essential when interpreting potency.
Comparing inhibitors by IC50 can rank their apparent potency within a common assay, but the comparison is most reliable when experimental conditions are standardized. Differences in substrate concentration, incubation time, or target system can change the measured values independently of intrinsic compound behavior. IC50 data therefore support comparison best when the compounds are evaluated under matched conditions.
To determine the value, researchers expose the target system to a range of compound concentrations, measure the biological or biochemical response at each concentration, and fit the resulting measurements to a concentration-response curve. The midpoint of inhibition is then identified from that fitted relationship. This workflow links experimental dosing, response measurement, and quantitative curve analysis.
In chemistry and drug discovery, the measurement helps characterize how compounds interact with enzymes or receptors and provides a potency metric for comparing candidates. During compound optimization, teams can use changes in measured values to assess whether chemical modifications improve apparent inhibitory activity. Its usefulness is greatest when the assay design remains consistent across the compounds being evaluated.
An IC50 result should be reported with the conditions needed to interpret it, including the substrate concentration when relevant, incubation time, and experimental system. These details indicate how the target response was generated and whether another experiment is comparable. Standardized methods make values more useful for evaluating inhibitor series, characterizing interactions, and guiding decisions in discovery research.